Xoma reported $5.17M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Agenus AGEN:US $ 61.4M 12.89M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Ardelyx ARDX:US $ 28.28M 8.03M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Celldex Therapeutics CLDX:US $ 23.43M 2.76M
Chimerix CMRX:US 24.79M 14.79M
Curis CRIS:US $ 17.19M 1.49M
Eli Lilly And LLY:US $ 5405.7M 677M
Emergent Biosolutions EBS:US $ 301.1M 144.7M
Epizyme EPZM:US $ 59.62M 3.25M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Life Technologies LIFE:US $ 12.38M 3.74M
Macrogenics MGNX:US $ 77.74M 5.36M
Novartis NOVN:VX 9.96B 998M
Novartis NVS:US 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Prothena PRTA:US 39.1M 4.83M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Teva Pharmaceutical Industries TEVA:US 4.37B 352M
Xoma XOMA:US $ 5.17M 408K
YTE INCY:US $ 616.69M 135.42M